Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2026-01-06 @ 12:57 AM
Study NCT ID:
NCT03379493
Status:
TERMINATED
Last Update Posted:
2019-02-04
First Post:
2017-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma
Sponsor:
Eureka Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-13
First Submit QC Date:
None
Study First Post Date:
2017-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-31
Last Update Post Date:
2019-02-04
Last Update Post Date Type:
ACTUAL